the aid library

LIST OPTIONS

Filter

23799

Download (268)

View PDF (430)

S1-Leitlinie Post-COVID/Long-COVID

Koczulla, A Rembert (2021) CC

AWMF Leitlinie, 12.7.2021

Cameroun : de la réorientation des soins de santé primaires au plan national de développement sanitaire

Okalla R.; A. Le Vigouroux (2001) C1

Bulletin de l'APAD, 21 | 2001

External Link

Review Challenges in Chagas Disease Drug Development

Francisco, A.; Jayawardhana, S.; Olmo, F. et al. Molecules MDPI (2020) CC

The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects. Advances in this area have been compromised by gaps... more

External Link

Monkeypox and pregnancy: what do obstetricians need to know?

Khalil, A.; et al. (2022) C2

Download (161)

View PDF (309)

Eliminating Trachoma in Africa: The Importance of Environmental Interventions

Ageed, A.; and M.Khan (2024) CC

Cureus 2024 Jan 16;16(1):e52358. doi: 10.7759/cureus.52358

Download (456)

View PDF (647)

Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation

I. A. Vasilyeva Russian Ministry of Health (2017) C1

Accessed November 2017

Download (228)

View PDF (380)

Guia nacional para el maejo de la enfermedad por el virus de la chikungunya

Dr. nava A.; Dr. Barabara Parada C.; Camaqui Mendoza A.; Dr. Flores Velasco O. et al. Ministerio de Salud Bolivia (2015) C2

La Enfermedad por el Virus de la Chikungunya – EVCH fue descrita por primera vez durante un brote ocurrido en 1952 al sur de Tanzania, su nombre es de origen makonde, grupo étnico que vive en esa región, que significa “aquel que se encorva” o “retorcido”, que describe la apariencia inc... more

Download (12709)

View PDF (1807)

Manual of Diagnostic Ultrasound in Infectious Tropical Diseases

Harald T. Lutz Hassen A. Gharbi Springer (2006)

External Link

La enfermedad de Chagas y sus Principales Vectores en Brasil

Argolo, A.; Felix, M.; Pacheco, R. et al Programa Integrado de la Enfermedad de Chagas PIDC - Instituto Oswaldo Cruz (2008) C2

Esta publicación tiene como objetivo fundamental, presentar en lenguaje claro y objetivo, informaciones actualizadas sobre las formas de transmisión de la enfermedad, sus vectores, su ciclo biológico y métodos de control. Su contenido se dirige, principalmente, a los técnicos y profesionales ... more

Download (168)

View PDF (120)

Occupational COPD—The most under-recognized occupational lung disease?

Mugia, N.; Gambelunghe, A. John Wiley & Sons Australia, Ltd (Respirology) (2022) CC2

The article discusses chronic obstructive pulmonary disease (COPD) as a common but under-recognized occupational disease. While smoking is the main cause, occupational exposure to vapors, gases, dusts, and fumes (VGDF) significantly contributes to the development and progression of COPD. Epidemiolog... more

External Link

External Link (580)

Malaria – Infectious Diseases – MSD Manual Professional Edition

Chelsea M., William A.P. jr. MSD Manual Professional Version (2025) C2

The article "Malaria – MSD Manual Professional Edition" provides a comprehensive overview of malaria, an infection caused by Plasmodium species. It describes symptoms such as fever, chills, and anemia, explains diagnostic methods like parasite detection in blood smears, and discusses treatment opt... more

Download (218)

View PDF (470)

журнал психиатрия 1`2014

Гаврилова С.И, Aлесенко А.В., Mолочкина Е.М. et al. ФГБНУ «Научный центр психического здоровья» (2014) C2

Материалы научно-практической конференции с международным участием «Достижения в нейробиологии и терапии болезни Альцгеймера», посвященной памяти профессора Э.�... more

External Link

External Link (225)

Chinese health funding in Africa: The untold story

Dolan C.B., Malik A.A., Zhang S., et al. PLOS Global Public Health (2023) CC

The motivations behind China’s allocation of health aid to Africa remain complex due to limited information on the details of health aid project activities. Insufficient knowledge about the purpose of China’s health aid hinders our understanding of China’s comprehensive role in supporting Afri... more

External Link

China’s hidden role in malaria control and elimination in Africa

Odhiambo J.N., Dolan C., Malik A.A., et al. BMJ Global Health (2023) CC

Insufficient funding is hindering the achievement of malaria elimination targets in Africa, despite the pressing need for increased investment in malaria control. While Western donors attribute their inaction to financial constraints, the global health community has limited knowledge of China’s ex... more

External Link

External Link (232)

Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002–17

Dingle, A.; Schäferhoff, M.; Borghi, J. et al. The Lancet (2020) CC

Background Four methods have previously been used to track aid for reproductive, maternal, newborn, and child health (RMNCH). At a meeting of donors and stakeholders in May, 2018, a single, agreed method was requested to produce accurate, predictable, transparent, and up-to-date estimates that coul...d be used for analyses from both donor and recipient perspectives. Muskoka2 was developed to meet these needs. We describe Muskoka2 and present estimates of levels and trends in aid for RMNCH in 2002–17, with a focus on the latest estimates for 2017. Methods Muskoka2 is an automated algorithm that generates disaggregated estimates of aid for reproductive health, maternal and newborn health, and child health at the global, donor, and recipient-country levels. We applied Muskoka2 to the Organisation for Economic Co-operation and Development's Creditor Reporting System (CRS) aid activities database to generate estimates of RMNCH disbursements in 2002–17. The percentage of disbursements that benefit RMNCH was determined using CRS purpose codes for all donors except Gavi, the Vaccine Alliance; the UN Population Fund; and UNICEF; for which fixed percentages of aid were considered to benefit RMNCH. We analysed funding by donor for the 20 largest donors, by recipient-country income group, and by recipient for the 16 countries with the greatest RMNCH need, defined as the countries with the worst levels in 2015 on each of seven health indicators. Findings After 3 years of stagnation, reported aid for RMNCH reached $15·9 billion in 2017, the highest amount ever reported. Among donors reporting in both 2016 and 2017, aid increased by 10% ($1·4 billion) to $15·4 billion between 2016 and 2017. Child health received almost half of RMNCH disbursements in 2017 (46%, $7·4 billion), followed by reproductive health (34%, $5·4 billion), and maternal and newborn health (19%, $3·1 billion). The USA ($5·8 billion) and the UK ($1·6 billion) were the largest bilateral donors, disbursing 46% of all RMNCH funding in 2017 (including shares of their core contributions to multilaterals). The Global Fund and Gavi were the largest multilateral donors, disbursing $1·7 billion and $1·5 billion, respectively, for RMNCH from their core budgets. The proportion of aid for RMNCH received by low-income countries increased from 31% in 2002 to 52% in 2017. Nigeria received 7% ($1·1 billion) of all aid for RMNCH in 2017, followed by Ethiopia (6%, $876 million), Kenya (5%, $754 million), and Tanzania (5%, $751 million). Interpretation Muskoka2 retains the speed, transparency, and donor buy-in of the G8's previous Muskoka approach and incorporates eight innovations to improve precision. Although aid for RMNCH increased in 2017, low-income and middle-income countries still experience substantial funding gaps and threats to future funding. Maternal and newborn health receives considerably less funding than reproductive health or child health, which is a persistent issue requiring urgent attention. Funding Bill & Melinda Gates Foundation; Partnership for Maternal, Newborn & Child Health. more

Download (153)

View PDF (147)

Banque de questionspour le personnel de santé lors épidemiés de maladies infectieuse

Wilkinson, A. Social Science in Humanitarian Action Platform (2025) C1

Cette banque de questions est un menu de questions qualitatives relatives aux connaissances, aux perceptions et aux pratiques du personnel de santé lors d'épidémies de maladies infectieuses. La banque de questions générera des données qualitatives sur la compréhension subjective qu'ont les pr... more

External Link

Drugs for Intermittent Preventive Treatment of Malaria in Pregnancy: Current Knowledge and Way Forward

Figueroa-Romero, A.; C. Pons-Duran, and R. Gonzalez (2022) CC

Trop. Med. Infect. Dis. 2022, 7, 152. https://doi.org/10.3390/tropicalmed7080152

Download (35)

View PDF (31)

Drug Resistant Malaria. Current Status

Pareek, A. (2024) C_WHO

Presentation

External Link

External Link (67)

Identification and management of co-infections in people with malaria

Cunnington, A.; A. Abbara, F. Kaduni Bawa, et al. (2024) CC2

BMJ 2024 Mar 13:384:e077512. doi: 10.1136/bmj-2023-077512. Co-infections in individuals with malaria are common, particularly in endemic areas, and can significantly impact disease severity and outcomes. Effective management requires prompt diagnosis of both malaria and any co-occurring infections,... more

External Link

Malaria vaccines: the 60‑year journey of hope and final success—lessons learned and future prospects

El‑Moamly, A.A.; and M. A. El‑Sweify (2023) CC

Tropical Medicine and Health (2023) 51:29